| |
 |
|
|
|
|
|
Poster: 103
Visits: 40
Title: First report of safety and efficacy of a glycoPEGylated FVIII (N8-GP) in previously treated pediatric patients with severe hemophilia Aresults from the international phase 3 pathfinder5 trial
Authors: Sandrine Meunier ,
Centre: 1CHU de Lyon
|
|
You must be registered to reply or comment.
|
|
FIRST REPORT OF SAFETY AND EFFICACY OF A GLYCOPEGYLATED FVIII (N8-GP) IN PREVIOUSLY TREATED PEDIATRIC PATIENTS WITH SEVERE HEMOPHILIA ARESULTS FROM THE INTERNATIONAL PHASE 3 PATHFINDER5 TRIAL
|
|
| You must be registered to reply or comment. |
|
|
|
|
|
|
| Most viewed poster for this congress |
|
|
Poster: 13
Visits: 590
Title: Algorithmic evidence-based phenotype screening and collaborative approach to attacking symptoms of nonadherence in patients with bleeding disorders
Authors: Jay Bryant-Wimp , Jay Bryant-Wimp, RPh
Centre: Integrite Solutions
|
|
|
|
|
|
|
| Poster most viewed in this topic |
|
|
Poster: 97
Visits: 120
Title: Safety and efficacy of turoctocog alfa for prophylaxis and treatment of bleeding episodes in patients with severe hemophilia A: results from the guardian2 trial
Authors: Elena Santagostino ,
Centre: Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Maggiore Hospital Policlinico, Milan, Italy
|
|
|
|
